USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: X-IN8 BIOLOGICALS CORPORATION
City: CHAPEL HILL
State: NC
Zip+4: 27517-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $291,826.00 1
STTR Phase I $321,746.00 1

Award List:

The effect of TLR4 inhibition on lung transplant ischemia-reperfusion injury

Award Year / Program / Phase: 2010 / STTR / Phase I
Agency: HHS
Research Institution: University Of North Carolina Chapel Hill
Principal Investigator: Perry A. Genova – 919-619-0388
Award Amount: $321,746.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Ischemia-reperfusion injury (IRI) occurs in organs when circulation is interrupted, causing ischemia, and then ischemic tissue is reperfused. This leads to a series of biologic consequences, resulting in edema and inflammation. IRI is a significant problem in… More

TLR4 Inhibition to Reduce Cerebral Ischemia Reperfusion Injury

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: M. N. Ellis – 919-619-0388
Award Amount: $291,826.00
Abstract:
DESCRIPTION (provided by applicant): ABSTRACT Interruption and subsequent restoration of circulation in tissues causes varying amounts of ischemia- reperfusion injury (IRI). IRI is a detrimental feature of many clinical events such as organ transplants, cardiopulmonary bypass (CPB) used in… More